Economic Burden of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

Masato Sakon, Yoshihiko Maehara, Takao Kobayashi, Hiroshi Kobayashi, Toru Shimazui, Norimasa Seo, Bruce Crawford, Izuru Miyoshi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Venous thromboembolism (VTE) is a serious complication that arises after major abdominal surgery. VTE poses risks of negative outcomes and health care burden. The literature on the cost of VTE in Japanese surgical patients, however, is scarce. Objective: This study was conducted to investigate the economic consequences of VTE in Japanese patients with major abdominal surgery, using a hospital claims database. Methods: This is a retrospective, matched cohort study. Patients who had a VTE event up to 90 days after their first major abdominal surgery and initiated warfarin or heparin within 1 day of VTE diagnosis with continued treatment for more than 4 weeks were matched with controls for surgery type, hospital, and date of surgery ± 6 months in a 1:2 scheme. The primary outcome was 90-day costs associated with major abdominal surgery. The secondary outcomes were 6-month total costs, average length of initial inpatient stay, and cost of initial inpatient stay. Results: The 90-day cumulative incidence of VTE was 4.89%. The development of a VTE event in patients undergoing major abdominal surgery resulted in a 1.5-fold increase in the length of hospitalization and a 2.8-fold increase in total costs 90 days after the surgery. Total costs further increased to 3.4-fold at 6 months. Overall, costs incurred in patients with VTE are on average much higher than in patients without VTE throughout 6-month postsurgery. Conclusions: The preventive care for VTE using more effective prophylactic treatment is recommended to reduce the economic burden associated with major abdominal surgery.

Original languageEnglish
Pages (from-to)73-79
Number of pages7
JournalValue in Health Regional Issues
Volume6
DOIs
Publication statusPublished - May 1 2015

Fingerprint

Venous Thromboembolism
Economics
Costs and Cost Analysis
Inpatients
Surgery
Burden
Preventive Medicine
Costs
Warfarin
Ambulatory Surgical Procedures
Heparin
Hospitalization
Cohort Studies
Databases
Delivery of Health Care

All Science Journal Classification (ASJC) codes

  • Economics, Econometrics and Finance (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Health Policy

Cite this

Sakon, M., Maehara, Y., Kobayashi, T., Kobayashi, H., Shimazui, T., Seo, N., ... Miyoshi, I. (2015). Economic Burden of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery. Value in Health Regional Issues, 6, 73-79. https://doi.org/10.1016/j.vhri.2015.03.017

Economic Burden of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery. / Sakon, Masato; Maehara, Yoshihiko; Kobayashi, Takao; Kobayashi, Hiroshi; Shimazui, Toru; Seo, Norimasa; Crawford, Bruce; Miyoshi, Izuru.

In: Value in Health Regional Issues, Vol. 6, 01.05.2015, p. 73-79.

Research output: Contribution to journalArticle

Sakon, M, Maehara, Y, Kobayashi, T, Kobayashi, H, Shimazui, T, Seo, N, Crawford, B & Miyoshi, I 2015, 'Economic Burden of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery', Value in Health Regional Issues, vol. 6, pp. 73-79. https://doi.org/10.1016/j.vhri.2015.03.017
Sakon, Masato ; Maehara, Yoshihiko ; Kobayashi, Takao ; Kobayashi, Hiroshi ; Shimazui, Toru ; Seo, Norimasa ; Crawford, Bruce ; Miyoshi, Izuru. / Economic Burden of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery. In: Value in Health Regional Issues. 2015 ; Vol. 6. pp. 73-79.
@article{7f4328bf613d4d42b43fc8de508c3612,
title = "Economic Burden of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery",
abstract = "Background: Venous thromboembolism (VTE) is a serious complication that arises after major abdominal surgery. VTE poses risks of negative outcomes and health care burden. The literature on the cost of VTE in Japanese surgical patients, however, is scarce. Objective: This study was conducted to investigate the economic consequences of VTE in Japanese patients with major abdominal surgery, using a hospital claims database. Methods: This is a retrospective, matched cohort study. Patients who had a VTE event up to 90 days after their first major abdominal surgery and initiated warfarin or heparin within 1 day of VTE diagnosis with continued treatment for more than 4 weeks were matched with controls for surgery type, hospital, and date of surgery ± 6 months in a 1:2 scheme. The primary outcome was 90-day costs associated with major abdominal surgery. The secondary outcomes were 6-month total costs, average length of initial inpatient stay, and cost of initial inpatient stay. Results: The 90-day cumulative incidence of VTE was 4.89{\%}. The development of a VTE event in patients undergoing major abdominal surgery resulted in a 1.5-fold increase in the length of hospitalization and a 2.8-fold increase in total costs 90 days after the surgery. Total costs further increased to 3.4-fold at 6 months. Overall, costs incurred in patients with VTE are on average much higher than in patients without VTE throughout 6-month postsurgery. Conclusions: The preventive care for VTE using more effective prophylactic treatment is recommended to reduce the economic burden associated with major abdominal surgery.",
author = "Masato Sakon and Yoshihiko Maehara and Takao Kobayashi and Hiroshi Kobayashi and Toru Shimazui and Norimasa Seo and Bruce Crawford and Izuru Miyoshi",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.vhri.2015.03.017",
language = "English",
volume = "6",
pages = "73--79",
journal = "Value in Health Regional Issues",
issn = "2212-1099",
publisher = "Elsevier USA",

}

TY - JOUR

T1 - Economic Burden of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

AU - Sakon, Masato

AU - Maehara, Yoshihiko

AU - Kobayashi, Takao

AU - Kobayashi, Hiroshi

AU - Shimazui, Toru

AU - Seo, Norimasa

AU - Crawford, Bruce

AU - Miyoshi, Izuru

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Background: Venous thromboembolism (VTE) is a serious complication that arises after major abdominal surgery. VTE poses risks of negative outcomes and health care burden. The literature on the cost of VTE in Japanese surgical patients, however, is scarce. Objective: This study was conducted to investigate the economic consequences of VTE in Japanese patients with major abdominal surgery, using a hospital claims database. Methods: This is a retrospective, matched cohort study. Patients who had a VTE event up to 90 days after their first major abdominal surgery and initiated warfarin or heparin within 1 day of VTE diagnosis with continued treatment for more than 4 weeks were matched with controls for surgery type, hospital, and date of surgery ± 6 months in a 1:2 scheme. The primary outcome was 90-day costs associated with major abdominal surgery. The secondary outcomes were 6-month total costs, average length of initial inpatient stay, and cost of initial inpatient stay. Results: The 90-day cumulative incidence of VTE was 4.89%. The development of a VTE event in patients undergoing major abdominal surgery resulted in a 1.5-fold increase in the length of hospitalization and a 2.8-fold increase in total costs 90 days after the surgery. Total costs further increased to 3.4-fold at 6 months. Overall, costs incurred in patients with VTE are on average much higher than in patients without VTE throughout 6-month postsurgery. Conclusions: The preventive care for VTE using more effective prophylactic treatment is recommended to reduce the economic burden associated with major abdominal surgery.

AB - Background: Venous thromboembolism (VTE) is a serious complication that arises after major abdominal surgery. VTE poses risks of negative outcomes and health care burden. The literature on the cost of VTE in Japanese surgical patients, however, is scarce. Objective: This study was conducted to investigate the economic consequences of VTE in Japanese patients with major abdominal surgery, using a hospital claims database. Methods: This is a retrospective, matched cohort study. Patients who had a VTE event up to 90 days after their first major abdominal surgery and initiated warfarin or heparin within 1 day of VTE diagnosis with continued treatment for more than 4 weeks were matched with controls for surgery type, hospital, and date of surgery ± 6 months in a 1:2 scheme. The primary outcome was 90-day costs associated with major abdominal surgery. The secondary outcomes were 6-month total costs, average length of initial inpatient stay, and cost of initial inpatient stay. Results: The 90-day cumulative incidence of VTE was 4.89%. The development of a VTE event in patients undergoing major abdominal surgery resulted in a 1.5-fold increase in the length of hospitalization and a 2.8-fold increase in total costs 90 days after the surgery. Total costs further increased to 3.4-fold at 6 months. Overall, costs incurred in patients with VTE are on average much higher than in patients without VTE throughout 6-month postsurgery. Conclusions: The preventive care for VTE using more effective prophylactic treatment is recommended to reduce the economic burden associated with major abdominal surgery.

UR - http://www.scopus.com/inward/record.url?scp=84929069100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929069100&partnerID=8YFLogxK

U2 - 10.1016/j.vhri.2015.03.017

DO - 10.1016/j.vhri.2015.03.017

M3 - Article

AN - SCOPUS:84929069100

VL - 6

SP - 73

EP - 79

JO - Value in Health Regional Issues

JF - Value in Health Regional Issues

SN - 2212-1099

ER -